Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience2001Chen JF, Xu K, Petzer JP, et al.
抄録
cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。
MeSH
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine3,4-Dihydroxyphenylacetic AcidAnimalsCaffeineCatecholsCorpus StriatumDisease Models, AnimalDopamineDose-Response Relationship, DrugImmunity, InnateInjections, IntraperitonealMaleMiceMice, Inbred C57BLMice, KnockoutNeuroprotective AgentsParkinsonian DisordersPurinergic P1 Receptor AntagonistsPurinesPyrimidinesReceptor, Adenosine A2AReceptors, Purinergic P1TheobromineTriazolesXanthines
DOI 10.1523/jneurosci.21-10-j0001.2001
PMID 11319241
原文・出典を見る →